Pinned Tweet
Excited to share our upcoming presentations at #ASCO2026 from the @HasanovLab @OhioStatePIIO and collaborators.
This year, our team will present 12 studies spanning:
hasanov-lab.github.io/publications/
🤖 AI/ML precision oncology
🧠 RCC brain metastasis biology
🧫 Spatial & single-cell trand outcomes research with ML models
💻 In silico clinical trial modeling
These projects reflect our 💻 #CodetoClinic 👩⚕️👨⚕️translational framework, integrating computational oncology, multi-omics, and clinical research to advance precision cancer care.
Grateful to our incredible trainees, collaborators, patients, and mentors who made this work possible. hasanov-lab.github.io/team/
@OSUCCC_James @ASCOPost @ASCO @KidneyCancer @kidneycan @urotoday @OncoAlert @oncodaily @OncLive
#KidneyCancer #BrainMetastases #PrecisionOncology #AIinOncology #SpatialBiology #SingleCell #TranslationalResearch
This year, our team will present 12 studies spanning:
hasanov-lab.github.io/publications/
🤖 AI/ML precision oncology
🧠 RCC brain metastasis biology
🧫 Spatial & single-cell trand outcomes research with ML models
💻 In silico clinical trial modeling
These projects reflect our 💻 #CodetoClinic 👩⚕️👨⚕️translational framework, integrating computational oncology, multi-omics, and clinical research to advance precision cancer care.
Grateful to our incredible trainees, collaborators, patients, and mentors who made this work possible. hasanov-lab.github.io/team/
@OSUCCC_James @ASCOPost @ASCO @KidneyCancer @kidneycan @urotoday @OncoAlert @oncodaily @OncLive
#KidneyCancer #BrainMetastases #PrecisionOncology #AIinOncology #SpatialBiology #SingleCell #TranslationalResearch
3
7
26
3,615
Elshad Hasanov, MD, PhD retweeted
Proud to represent @OSUCCC_James @OSUWexMed @OSU_Urology with @HasanovLab and @lingbin_meng in Bermuda at the 9th Annual Summit on GU Malignancies!
0
2
10
338
Elshad Hasanov, MD, PhD retweeted
Coming up Next: SETTING THE STAGE - RENAL CELL CARCINOMA
Moderator: Dr. Scott Tykodi
The session will explore translational research, HIF2α inhibitors, VHL care & AI modelling, featuring Drs. Brugarolas, Jonasch, Ball & Hasanov
#DAVAGU
Moderator: Dr. Scott Tykodi
The session will explore translational research, HIF2α inhibitors, VHL care & AI modelling, featuring Drs. Brugarolas, Jonasch, Ball & Hasanov
#DAVAGU
0
2
5
164
Elshad Hasanov, MD, PhD retweeted
Some evenings remind you why you love this field. Last night in Pittsburgh was one of them. 💙
Thank you to everyone who filled the room at Cancer Updates From Major Oncology Meetings – Pittsburgh. It was an honor to co-chair this program with Dr. Adam brufsky and to share the alignancies.
The science was excellent, but I'll remember the energy in the room most. Oncologists, APPs, nurses, pharmacists, and fellows came together after a full day at work. The questions were thoughtful, the hallway conversations ran long, and colleagues who hadn't seen each other met up.
Coming back to Pittsburgh always feels like coming home. So many of the people in that room worked with me, referred patients to me, or cared for patients alongside me over the years. The oncology community here is one of the strongest anywhere.
Meetings like this matter. A trial result becomes better care only when colleagues talk it through together, compare notes, and take it back to their patients.
Thank you to Total Health, our faculty, Dr. Elshad Hasanov, Dulabh Kaur Monga, Christopher Lemmon, and everyone who joined us! @UPMCHillmanCC @TotalHealthConf @CyrusKhann @HasanovLab #hemonc @oncodaily @AJMC_Journal @BloodCancerUtd @aamdsif
#MedTwitter: #OncTwitter:
#mmsm #lymsm , #leusm #MPNsm
Thank you to everyone who filled the room at Cancer Updates From Major Oncology Meetings – Pittsburgh. It was an honor to co-chair this program with Dr. Adam brufsky and to share the alignancies.
The science was excellent, but I'll remember the energy in the room most. Oncologists, APPs, nurses, pharmacists, and fellows came together after a full day at work. The questions were thoughtful, the hallway conversations ran long, and colleagues who hadn't seen each other met up.
Coming back to Pittsburgh always feels like coming home. So many of the people in that room worked with me, referred patients to me, or cared for patients alongside me over the years. The oncology community here is one of the strongest anywhere.
Meetings like this matter. A trial result becomes better care only when colleagues talk it through together, compare notes, and take it back to their patients.
Thank you to Total Health, our faculty, Dr. Elshad Hasanov, Dulabh Kaur Monga, Christopher Lemmon, and everyone who joined us! @UPMCHillmanCC @TotalHealthConf @CyrusKhann @HasanovLab #hemonc @oncodaily @AJMC_Journal @BloodCancerUtd @aamdsif
#MedTwitter: #OncTwitter:
#mmsm #lymsm , #leusm #MPNsm
0
2
13
567
Elshad Hasanov, MD, PhD retweeted
📝New publication from Merve Hasanov in Neuro-Oncology Advances: Clinical factors associated with leptomeningeal disease in patients with melanoma brain metastasis
doi.org/10.1093/noajnl…
doi.org/10.1093/noajnl…
0
4
9
543
Elshad Hasanov, MD, PhD retweeted
🌍 Two days of connection, learning and collaboration!
The 2026 IKCC Global Kidney Cancer Summit brought together more than 50 patient advocates, healthcare professionals and kidney cancer experts from around the world in Prague, Czech Republic, on 10–11 October.
The 2026 IKCC Global Kidney Cancer Summit brought together more than 50 patient advocates, healthcare professionals and kidney cancer experts from around the world in Prague, Czech Republic, on 10–11 October.
1
1
2
187
Elshad Hasanov, MD, PhD retweeted
Congratulations to @OSUCCC_James, @OhioStateMedOnc, #PIIO physician-scientist, Dr. Elshad Hasanov (@HasanovLab) on receiving a @GatewayforCR award to fund ZUMRA study, a multicenter phase II clinical trial for patients with #KidneyCancer and #BrainMetastasis!
ZUMRA study will e or in combination with belzutifan in patients with untreated or progressive #BrainMetastases, a population often excluded from major clinical trials.
The study will evaluate whether these treatments shrink brain metastases, while also assessing safety, duration of cancer control, and survival.
An important step toward expanding treatment options and bringing hope to patients with challenging-to-treat kidney cancer.
#KidneyCancer #ClinicalTrials #CancerResearch
ZUMRA study will e or in combination with belzutifan in patients with untreated or progressive #BrainMetastases, a population often excluded from major clinical trials.
The study will evaluate whether these treatments shrink brain metastases, while also assessing safety, duration of cancer control, and survival.
An important step toward expanding treatment options and bringing hope to patients with challenging-to-treat kidney cancer.
#KidneyCancer #ClinicalTrials #CancerResearch
0
7
21
730
Elshad Hasanov, MD, PhD retweeted
👏Congrats to @HasanovLab on receiving a @GatewayforCR award for a multicenter phase 2 study of zanzalintinib & combination therapies in untreated or progressive brain metastases in renal cell carcinoma
1
5
12
568
Elshad Hasanov, MD, PhD retweeted
🎊Congratulations🎊 to our own @eric_facs who was recognized as an @OSUCCC_James 2026 Service Line Physician Champion at the recent Annual James Physician Recognition Celebration! We’re proud to celebrate this well-deserved award and Dr. Singer’s dedication to our patients 👏
0
4
32
1,416
Elshad Hasanov, MD, PhD retweeted
📢 Today, on World Cancer Research Day, the 5th IKCC Global Patient Survey on Kidney Cancer is now open!
People who have been diagnosed with kidney cancer and carers are invited to share patient experiences and insights in the online survey:
bit.ly/IKCC_Kidney_Ca…
People who have been diagnosed with kidney cancer and carers are invited to share patient experiences and insights in the online survey:
bit.ly/IKCC_Kidney_Ca…
1
1
4
1,984
Elshad Hasanov, MD, PhD retweeted
🧬 Join #PIIO for a Special Research Seminar featuring Dr. @HindRafei, Assistant Professor and Physician-Scientist at UT MD Anderson Cancer Center.
🔬 “Targeting cAMP signaling and metabolism to improve cellular immunotherapy in the tumor microenvironment”
📅 Sept. 16 | 12–1 PM
l be provided
#CancerResearch #Immunotherapy #CellTherapy
🔬 “Targeting cAMP signaling and metabolism to improve cellular immunotherapy in the tumor microenvironment”
📅 Sept. 16 | 12–1 PM
l be provided
#CancerResearch #Immunotherapy #CellTherapy
0
4
8
2,765
Elshad Hasanov, MD, PhD retweeted
📝New publication from @HasanovLab & colleagues in @ESMO_Open: Era-specific prognostic factors and an interpretable machine-learning survival model for renal cell carcinoma brain metastases doi.org/10.1016/j.esmo…
0
2
9
569
Elshad Hasanov, MD, PhD retweeted
Profoundly grateful for the continuous guidance of Dr. Elshad & Dr. Merve Hasanov, and the support of entire @HasanovLab @OSUCCC_James @OhioStatePIIO for making this possible.
@ASCO / @NeuroOnc #CNSMetastasesConference
@ASCO / @NeuroOnc #CNSMetastasesConference
Our trailblazer @ZuhairMajeed presented #BrainMetCompass at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference! 🧠🧭
💻 Try BrainMetCompass: …nmetcompass.share.connect.posit.cloud
🎯 PREDICT → PERSONALIZE → PREVENT
#BrainMetCompass is our #CodetoClinic ML model designed to predict an sk of developing brain metastases using clinical and tumor genomic data. Opening the door to personalized CNS surveillance, diagnosis at asymptomatic stage and ultimately prevention.
The model is patented by @OhioState and is available for licensing by interested sequencing companies. Proud of Zuhair and our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team for taking another step from #CodetoClinic.
3
1
11
1,521
Excited to share our new #insilicoMetMap model, developed by our 🌟💫🌟 PhD student @PengLi_AI
🧠💻
We asked a different question: Can we learn from METMAP experiments and predict brain-metastatic potential for cell lines that have never been tested?
Creating #insilicoMetMap and ike states and candidate biological targets for further experimental testing.
This is exactly how we envision #CodeToClinic: using existing experimental and multi-omics data to build computational models that can prioritize bench experiments, generate biological hypotheses, and potentially reduce the time and resources required for discovery.
Congratulations, Peng, and the entire @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team!
@NeuroOnc @ASCO
🧠💻
We asked a different question: Can we learn from METMAP experiments and predict brain-metastatic potential for cell lines that have never been tested?
Creating #insilicoMetMap and ike states and candidate biological targets for further experimental testing.
This is exactly how we envision #CodeToClinic: using existing experimental and multi-omics data to build computational models that can prioritize bench experiments, generate biological hypotheses, and potentially reduce the time and resources required for discovery.
Congratulations, Peng, and the entire @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team!
@NeuroOnc @ASCO
0
5
21
1,422
Our trailblazer @ZuhairMajeed presented #BrainMetCompass at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference! 🧠🧭
💻 Try BrainMetCompass: …nmetcompass.share.connect.posit.cloud
🎯 PREDICT → PERSONALIZE → PREVENT
#BrainMetCompass is our #CodetoClinic ML model designed to predict an sk of developing brain metastases using clinical and tumor genomic data. Opening the door to personalized CNS surveillance, diagnosis at asymptomatic stage and ultimately prevention.
The model is patented by @OhioState and is available for licensing by interested sequencing companies. Proud of Zuhair and our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team for taking another step from #CodetoClinic.
💻 Try BrainMetCompass: …nmetcompass.share.connect.posit.cloud
🎯 PREDICT → PERSONALIZE → PREVENT
#BrainMetCompass is our #CodetoClinic ML model designed to predict an sk of developing brain metastases using clinical and tumor genomic data. Opening the door to personalized CNS surveillance, diagnosis at asymptomatic stage and ultimately prevention.
The model is patented by @OhioState and is available for licensing by interested sequencing companies. Proud of Zuhair and our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team for taking another step from #CodetoClinic.
0
4
13
2,056
Our 🌟 PhD student @MostafaIHA is presenting two posters at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference.
One highlights our single-cell and spatial characterization of renal cell carcinoma brain metastases, uncovering how tumor cells adapt to the brain microenvironment and e and stromal landscape. bioRxiv preprint: pubmed.ncbi.nlm.nih.gov/42146564/
The second explores an interpretable machine-learning model integrating genomic mutations and copy-number alterations to predict survival across patients with brain metastases. academic.oup.com/noa/article/8/…
Proud to see Mostafa bringing together multi-omics, tumor biology, and AI #CodetoClinic as we work toward better understanding and treating brain metastasis.
Great work, Mostafa, and congratulations to the entire team @OSUCCC_James @OhioStatePIIO @OSUWexMed and our collaborators @UTMDAnderson @EmoryUniversity @Hacettepe1967 @EJonasch @bilenma @hanalioglu @ACasasent @nicholas_navin
#BrainMetastases #KidneyCancer #SingleCell #SpatialBiology #MachineLearning #PrecisionOncology
One highlights our single-cell and spatial characterization of renal cell carcinoma brain metastases, uncovering how tumor cells adapt to the brain microenvironment and e and stromal landscape. bioRxiv preprint: pubmed.ncbi.nlm.nih.gov/42146564/
The second explores an interpretable machine-learning model integrating genomic mutations and copy-number alterations to predict survival across patients with brain metastases. academic.oup.com/noa/article/8/…
Proud to see Mostafa bringing together multi-omics, tumor biology, and AI #CodetoClinic as we work toward better understanding and treating brain metastasis.
Great work, Mostafa, and congratulations to the entire team @OSUCCC_James @OhioStatePIIO @OSUWexMed and our collaborators @UTMDAnderson @EmoryUniversity @Hacettepe1967 @EJonasch @bilenma @hanalioglu @ACasasent @nicholas_navin
#BrainMetastases #KidneyCancer #SingleCell #SpatialBiology #MachineLearning #PrecisionOncology
0
5
23
2,050
Congratulations to 💫 biostatistician @Tubitak scholar @semihaxozgul on a special milestone: concurrent publications in @myESMO @ESMO_Open and @NeuroOnc #NeuroOncAdvances, alongside her poster presentation at the 2026 SNO/@ASCO #CNSMetastasesConference! 🎉
Her work, “Era-Specific an Interpretable Machine-Learning Survival Model for Renal Cell Carcinoma Brain Metastases,” brings together clinical oncology and interpretable AI to better understand outcomes and personalize prognostication for patients with RCC brain metastases.
Proud to see this work from our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team, in collaboration with @UTMDAnderson, move from data → #CodetoClinic.
📄 ESMO Open: sciencedirect.com/science/articl…
📄 Neuro-Oncology Advances #cofirst @ZuhairMajeed : academic.oup.com/noa/article/8/…
💻 Interactive models: hasanov-lab.github.io/tools/rcc-bm/
Congratulations, Semiha, and the entire team! 👏
#BrainMetastases #KidneyCancer #MachineLearning #PrecisionOncology #SNO2026 #ASCO
Her work, “Era-Specific an Interpretable Machine-Learning Survival Model for Renal Cell Carcinoma Brain Metastases,” brings together clinical oncology and interpretable AI to better understand outcomes and personalize prognostication for patients with RCC brain metastases.
Proud to see this work from our @OSUCCC_James @OhioStatePIIO @OhioStateMedOnc team, in collaboration with @UTMDAnderson, move from data → #CodetoClinic.
📄 ESMO Open: sciencedirect.com/science/articl…
📄 Neuro-Oncology Advances #cofirst @ZuhairMajeed : academic.oup.com/noa/article/8/…
💻 Interactive models: hasanov-lab.github.io/tools/rcc-bm/
Congratulations, Semiha, and the entire team! 👏
#BrainMetastases #KidneyCancer #MachineLearning #PrecisionOncology #SNO2026 #ASCO
5
8
24
1,626
Proud of our team at the 2026 @NeuroOnc @ASCO #CNSMetastasesConference in Boston, presenting 5 studies: 2 oral presentations and 3 posters, spanning AI/ML prediction of brain metastasis, multi-omics neural networks, genomic survival modeling, and single-cell characterization of xciting to see our trainees leading these efforts and advancing our mission to better predict, understand, and ultimately prevent brain metastasis.
#CodetoClinic #BrainMetastases #CNSMetastases #SNO2026 #ASCO #AI #PrecisionOncology
@OhioState @OSUCCC_James @OhioStateMedOnc @OhioStatePIIO
#CodetoClinic #BrainMetastases #CNSMetastases #SNO2026 #ASCO #AI #PrecisionOncology
@OhioState @OSUCCC_James @OhioStateMedOnc @OhioStatePIIO
3
10
29
2,044
No limits @Pelotonia Weekend
On every front in the fight against cancer. 💚 💚 💚
This weekend was a reminder that there are many ways to change the future of cancer care: caring for patients, advancing research, sharing science, educating colleagues, volunteering, fundraising, ng new collaborations on the bike. 🚴🏻🚴♀️🚴♂️
That’s what makes @Pelotonia so special. Every mile, every conversation, and every act of generosity brings us one step closer to a #CancerFreeWorld.
@HasanovLab proud to be part of this incredible community @Pelotonia @OhioStatePIIO @OhioStateMedOnc @OSUCCC_James @OSUWexMed @OhioState
On every front in the fight against cancer. 💚 💚 💚
This weekend was a reminder that there are many ways to change the future of cancer care: caring for patients, advancing research, sharing science, educating colleagues, volunteering, fundraising, ng new collaborations on the bike. 🚴🏻🚴♀️🚴♂️
That’s what makes @Pelotonia so special. Every mile, every conversation, and every act of generosity brings us one step closer to a #CancerFreeWorld.
@HasanovLab proud to be part of this incredible community @Pelotonia @OhioStatePIIO @OhioStateMedOnc @OSUCCC_James @OSUWexMed @OhioState
0
7
31
3,079
Elshad Hasanov, MD, PhD retweeted
🤖 #ArtificialIntelligence is helping unlock the future of #KidneyCancer care. At @OSUCCC_James, @Pelotonia-funded researcher Dr. Elshad Hasanov (@HasanovLab) is using #AI to identify which treatments may work best for each patient.
0
3
10
1,436